Wilson and Jungner, 1968 (1) | 10 | NA |
Cochrane and Holland, 1971 (12) | 7 | NA |
Whitby, 1974 (13) | 8 | NA |
Cuckle and Wald, 1984 (14) | 8 | NA |
Hakama et al., 1985 (15) | 8 | NA |
Sackett et al., 1985 (16) | 6 | NA |
Prorok and Connor, 1986 (17) | 9 | NA |
Health Council of the Netherlands, 1994 (18) | 21* | NA |
Braveman and Tarimo, 1996 (19) | 5 | NA |
Clark and Reintgen, 1996 (20) | 10 | (1) Characteristics of the disease, (2) Characteristics of the screening test |
Parsonnet and Axon, 1996 (21) | 6 | NA |
Fowler and Austoker, 1997 (22) | 9 | NA |
Gray, 1997 (23) | 5 | NA |
Seymour et al., 1997 (24) | 7 | NA |
Schoemaker, 1998 (25) | 10 | (1) Requirements for a suitable disease, (2) Requirements for a suitable screening procedure, (3) Requirements for a suitable treatment |
UK National Screening Committee, 1998 (26) | 17 | (1) Condition, (2) Test, (3) Treatment, (4) Screening program |
Nielsen and Lang, 1999 (27) | 6 | NA |
Prorok et al., 1999 (28) | 9 | NA |
American Academy of Pediatrics Newborn Screening Taskforce, 2000 (29) | 13* | NA |
UK National Screening Committee, 2000 (30) | 20* | (1) Condition, (2) Test, (3) Treatment, (4) Screening program |
Katz, 2001 (31) | 13 | (1) Disease specific, (2) Test specific, (3) Society or system specific |
Hanselaar, 2002 (32) | 14 | NA |
National Committee on Colorectal Cancer Screening (Canada), 2002 (33) | 9 | NA |
New Zealand National Health Committee, 2003 (34) | 8 | NA |
UK National Screening Committee, 2003 (35) | 23* | (1) Condition, (2) Test, (3) Treatment, (4) Screening program |
Harris and Kinsinger, 2005 (36) | 8 | NA |
Miller, 2005 (37) | 6* | NA |
Strong et al., 2005 (38) | 9 | NA |
Andermann et al., 2008 (39) | 10 | NA |
Bryant and Hamdy, 2008 (40) | 9 | NA |
Lewis et al., 2008 (41) | 20 | (1) Disease, (2) Diagnostic test, (3) Diagnosis and treatment, (4) Overall screening program |
Mandel and Smith, 2008 (42) | 12 | NA |
Andermann et al., 2011 (43) | 20 | (1) Laboratory testing level, (2) Clinical services level, (3) Program management level |
Grootendorst et al., 2009 (44) | 20 | (1) Condition, (2) Treatment, (3) Test used in screening, (4) Cost, (5) Screening program |
Harris et al., 2011 (45) | 7 | NA |
Martin-Moreno et al., 2012 (46) | 8 | Each principle described under 4 elements: (1) Governance, (2) Financing, (3) Resource generation, (4) Service delivery |
Petros, 2012 (47) | 21 | NA |
Adriaensen et al., 2013 (48) | 7 | (1) Technical accuracy, (2) Clinical pathway, (3) Diagnostic accuracy, (4) Longitudinal clinical sensitivity, (5) Impact on a patient level, (6) Impact on a population level and cost-effectiveness |
Forman et al., 2013 (49) | 14 | NA |
Lewis et al., 2014 (50) | 18 | (1) Disease, (2) Diagnostic test, (3) Diagnosis and treatment, (4) Overall screening program |
UK National Screening Committee, 2015 (51) | 20 | (1) Condition, (2) Test, (3) Intervention, (4) Screening program, (5) Implementation criteria |